Citazione Stile APA (7a Edizione)

Okura, E., Sakamoto, K., Maruyama, Y., Hirabayashi, K., Saito, S., Yanagisawa, R., & Nakazawa, Y. (2025). Ruxolitinib for preventing relapse of Epstein–Barr virus‐associated hemophagocytic lymphohistiocytosis. Wiley. https://doi.org/10.1111/ped.70032

Citazione stile Chigago Style (17a edizione)

Okura, Eri, Kenichi Sakamoto, Yuta Maruyama, Koichi Hirabayashi, Shoji Saito, Ryu Yanagisawa, e Yozo Nakazawa. Ruxolitinib for Preventing Relapse of Epstein–Barr Virus‐associated Hemophagocytic Lymphohistiocytosis. Wiley, 2025. https://doi.org/10.1111/ped.70032.

Citatione MLA (9a ed.)

Okura, Eri, et al. Ruxolitinib for Preventing Relapse of Epstein–Barr Virus‐associated Hemophagocytic Lymphohistiocytosis. Wiley, 2025. https://doi.org/10.1111/ped.70032.